Shift Health Collaborates with Alzheimer’s Disease Experts to Uncover the Priorities of Patients and Their Care Partners and Explore the Implications for Understanding the Value of Future Interventions
Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer’s Disease
From the Voices of People with Haemophilia A and Their Caregivers
COVID-19 and the Future of Health Research and Innovation
While many studies explore the cognitive and functional aspects of Alzheimer’s Disease, relatively less focus has been put on gaining a deeper understanding of patient and care partner priorities, particularly in the early stages where interventions may have the greatest impact in slowing or delaying progression.
We are pleased to share a recently published article “What Matters to Patients with Alzheimer’s Disease and Their Care Partners? Implications for Understanding the Value of Future Interventions,” which provides a brief overview of the emerging body of literature on the Alzheimer’s Disease continuum, summarizes what is understood about the impacts of the disease from the viewpoint of patients and their families, and outlines the emerging implications for future research and policy.
A key conclusion of the article is that there is a need to factor in the perspectives of patients and care partners to paint a fulsome picture of the impact of the disease on those most affected, guide clinical research priorities, and assess the full value of interventions.
The article was authored by:
Prof. Dr. Frank Jessen, Medical Faculty, University Hospital Cologne, Cologne, Germany; German Center for Neurodegenerative Diseases, Bonn | Cologne, Germany
Jean Georges, Executive Director of Alzheimer Europe, Luxembourg, Luxembourg
Marc Wortmann, CEO of Marc Wortmann Consultancy, Zeist, Netherlands
Samantha Benham-Hermetz, Alzheimer’s Research UK, Cambridge, United Kingdom
For more information, access the full article HERE.